These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Questionnaire survey about the motives of commercial livestock farmers and hobby holders to vaccinate their animals against Bluetongue virus serotype 8 in 2008-2009 in the Netherlands. Elbers AR; de Koeijer AA; Scolamacchia F; van Rijn PA Vaccine; 2010 Mar; 28(13):2473-81. PubMed ID: 20123141 [TBL] [Abstract][Full Text] [Related]
7. [What BTV-8 can do, any other serotype can do, too]. Haneveld JK Tijdschr Diergeneeskd; 2008 Oct; 133(20):856-8. PubMed ID: 18975627 [No Abstract] [Full Text] [Related]
8. Vaccination considered the only practical safeguard against bluetongue. Vet Rec; 2008 Feb; 162(7):194-5. PubMed ID: 18389575 [No Abstract] [Full Text] [Related]
9. [Vaccination against bluetongue: safety and immune response in the field]. Bruckner L; Fricker R; Hug M; Hotz R; Muntwyler J; Iten C; Griot C Schweiz Arch Tierheilkd; 2009 Mar; 151(3):101-8. PubMed ID: 19263379 [TBL] [Abstract][Full Text] [Related]
10. Vaccination in the control of bluetongue in endemic regions: the South African experience. Dungu B; Potgieter C; Von Teichman B; Smit T Dev Biol (Basel); 2004; 119():463-72. PubMed ID: 15742661 [TBL] [Abstract][Full Text] [Related]
11. Bluetongue in cattle: a review. Goltz J Can Vet J; 1978 Apr; 19(4):95-8. PubMed ID: 207405 [No Abstract] [Full Text] [Related]
12. Expected utility of voluntary vaccination in the middle of an emergent Bluetongue virus serotype 8 epidemic: a decision analysis parameterized for Dutch circumstances. Sok J; Hogeveen H; Elbers AR; Velthuis AG; Oude Lansink AG Prev Vet Med; 2014 Aug; 115(3-4):75-87. PubMed ID: 24768508 [TBL] [Abstract][Full Text] [Related]
13. Seroprevalence after vaccination of cattle and sheep against Bluetongue Virus (BTV) serotype 8 in Sweden. Hultén C; Frössling J; Chenais E; Sternberg Lewerin S Transbound Emerg Dis; 2013 Oct; 60(5):438-47. PubMed ID: 22889362 [TBL] [Abstract][Full Text] [Related]
14. [Bluetongue, current situation]. van Houten D Tijdschr Diergeneeskd; 2009 May; 134(9):409-10. PubMed ID: 19480153 [No Abstract] [Full Text] [Related]
15. Assessment of efficacy of a bivalent BTV-2 and BTV-4 inactivated vaccine by vaccination and challenge in cattle. Savini G; Hamers C; Conte A; Migliaccio P; Bonfini B; Teodori L; Di Ventura M; Hudelet P; Schumacher C; Caporale V Vet Microbiol; 2009 Jan; 133(1-2):1-8. PubMed ID: 18617335 [TBL] [Abstract][Full Text] [Related]
16. Bluetongue control in Europe--new challenges and achievements. Makoschey B; Maclachlan J; v Wuijckhuise L; Kirschvink N; dal Pozzo F; Petit H; Kaandorp-Huber C; v Rijn P; Sellal E; Oura C; Boinas F; Cavirani S; de Clercq K; Lucientes J; Meijjes CP; Zientara S; Meyer G; Thiry E Berl Munch Tierarztl Wochenschr; 2009; 122(7-8):314-24. PubMed ID: 19681404 [No Abstract] [Full Text] [Related]
17. Monitoring for bluetongue. Simpson V Vet Rec; 2009 Apr; 164(15):476. PubMed ID: 19363233 [No Abstract] [Full Text] [Related]
18. Possible adverse reactions in sheep after vaccination with inactivated BTV vaccines. González JM; Figueras L; Ortega ME; Lozano M; de Arcaute MR; Royo R; Cebrián LM; Ferrer LM; Fariñas F; de Jalón JA; De las Heras M Vet Rec; 2010 Jun; 166(24):757-8. PubMed ID: 20543167 [No Abstract] [Full Text] [Related]
19. Coordinating the approach to bluetongue. Brownlie J Vet Rec; 2008 Mar; 162(9):287. PubMed ID: 18310567 [No Abstract] [Full Text] [Related]